Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK31858 in non-cystic fibrosis bronchiectasis
NCT06660992Phase 3Recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Sep 2024
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HSK31858 in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Sep 2024; status: recruiting.
02
Drugs
HSK31858
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT06660992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06660992.